Phenotypic variations of TRAIL sensitivity in cloned populations of prostate cancer cells

Phenotypic variations of TRAIL sensitivity in cloned populations of prostate cancer cells

Εμφάνιση άλλων εκδόσεων (1)

Factors that regulate the induction of apoptosis of tumour cells are potential candidates for therapeutic intervention for the majority of cancers. Studying modifiers of apoptotic responses, such as members of the tumour necrosis factor receptor superfamily, may give clues as to how induction of apo...

Πλήρης περιγραφή

Λεπτομέρειες βιβλιογραφικής εγγραφής
Κύριοι συγγραφείς:	Cross, N, Waterman, E, Jokonya, N, Fowles, A, Buckle, C, Phillips, J, Holen, I, Hamdy, F, Eaton, C
Μορφή:	Journal article
Γλώσσα:	English
Έκδοση:	2008

Παρόμοια τεκμήρια

Phenotypic variations of TRAIL sensitivity in cloned populations of prostate cancer cells.
ανά: Cross, N, κ.ά.
Έκδοση: (2008)

Imaging the effects of castration on bone turnover and hormone-independent prostate cancer colonization of bone.
ανά: Cross, N, κ.ά.
Έκδοση: (2008)

Human bone marrow stromal cells protect prostate and breast cancer cells from TRAIL-induced apoptosis
ανά: Nyambo, R, κ.ά.
Έκδοση: (2004)

The expression and regulation of ADAMTS-1, -4, -5, -9, and -15, and TIMP-3 by TGFbeta1 in prostate cells: relevance to the accumulation of versican.
ανά: Cross, N, κ.ά.
Έκδοση: (2005)

Human bone marrow stromal cells protect prostate cancer cells from TRAIL-induced apoptosis.
ανά: Nyambo, R, κ.ά.
Έκδοση: (2004)

Analysis of the functional role of ADAMTS enzymes in prostate cancer
ανά: Molokwu, C, κ.ά.
Έκδοση: (2005)

The antibody MAB8051 directed against osteoprotegerin detects carbonic anhydrase II: implications for association studies with human cancers.
ανά: Waterman, E, κ.ά.
Έκδοση: (2007)

Osteoprotegerin (OPG) is a survival factor for human prostate cancer cells.
ανά: Holen, I, κ.ά.
Έκδοση: (2002)

Serum osteoprotegerin (OPG) levels and disease progression in prostate cancer patients
ανά: Eaton, C, κ.ά.
Έκδοση: (2004)

Expression pattern of the ADAMTS (A Disintegrin And Metalloproteinase with ThromboSpondin motifs) proteinases in human prostate cancer celllines
ανά: Chandrasekharan, S, κ.ά.
Έκδοση: (2003)

Osteoprotegerin is an anti-apoptotic factor produced by prostate cancer cells that is potentially involved in tumour survival and progression.
ανά: Holen, I, κ.ά.
Έκδοση: (2002)

Serum osteoprotegerin (OPG) levels are associated with disease progression and response to androgen ablation in patients with prostate cancer.
ανά: Eaton, C, κ.ά.
Έκδοση: (2004)

Human bone marrow stromal cell derived IGF signaling enhances PSA production as well as proliferation/survival of androgen sensitive prostate cancer cells in vitro
ανά: Papageorgiou, M, κ.ά.
Έκδοση: (2005)

EZH2 promotes proliferation and invasiveness of prostate cancer cells.
ανά: Bryant, R, κ.ά.
Έκδοση: (2007)

Evaluating the role of ADAMTS proteoglycanases and TIMP-3 in prostate cancer progression
ανά: Adeniji, O, κ.ά.
Έκδοση: (2007)

TIMP-3 expression is regulated by androgen and TNF in prostate stromal and cancer cells
ανά: Adeniji, O, κ.ά.
Έκδοση: (2008)

TIMP-3 expression in prostate stromal and tumour cells is regulated by androgen and TNF
ανά: Adeniji, O, κ.ά.
Έκδοση: (2007)

The role of osteoprotegerin in breast and prostate cancer
ανά: Holen, I, κ.ά.
Έκδοση: (2002)

BMP-6 over-expression in prostate cancer is associated with increased Id-1 protein and a more invasive phenotype.
ανά: Darby, S, κ.ά.
Έκδοση: (2008)

OPG is a survival factor for breast- and prostate cancer cells in vitro
ανά: Holen, I, κ.ά.
Έκδοση: (2002)

The polycomb group protein EZH2 is required for transcriptional repression of p21 and MMP7 in prostate cancer cells
ανά: Bryant, R, κ.ά.
Έκδοση: (2007)

Trailing TRAIL Resistance: Novel Targets for TRAIL sensitization in Cancer cells
ανά: RACHANA eTRIVEDI, κ.ά.
Έκδοση: (2015-04-01)

Qualitative and quantitative PSA mRNA detection in prostate cancer - A useful tool for the clinician?
ανά: Phillips, J, κ.ά.
Έκδοση: (2007)

Dystroglycan function is a novel determinant of tumor growth and behavior in prostate cancer.
ανά: Mitchell, A, κ.ά.
Έκδοση: (2013)

High susceptibility of metastatic cells derived from human prostate and colon cancer cells to TRAIL and sensitization of TRAIL-insensitive primary cells to TRAIL by 4,5-dimethoxy-2-nitrobenzaldehyde
ανά: Lee Jae-Won, κ.ά.
Έκδοση: (2011-04-01)

Bone marrow stromal cell-derived insulin-like growth factor (IGF) II enhances growth and survival of prostate cancer cells and potentiates androgen action
ανά: Cross, N, κ.ά.
Έκδοση: (2007)

HIV induces TRAIL sensitivity in hepatocytes.
ανά: Challagundla K Babu, κ.ά.
Έκδοση: (2009-01-01)

The emphysematous lung is abnormally sensitive to TRAIL-mediated apoptosis
ανά: Milot Julie, κ.ά.
Έκδοση: (2011-08-01)

Itraq-facilitated proteomic analysis of human prostate cancer cells identifies proteins associated with progression
ανά: Rehman, I, κ.ά.
Έκδοση: (2008)

Differential sensitivity of normal osteoblast-like cells and osteosarcoma cells to TRAIL and an agonist antibody to TRAIL receptor-2
ανά: Locklin, R, κ.ά.
Έκδοση: (2005)

iTRAQ-facilitated proteomic analysis of human prostate cancer cells identifies proteins associated with progression.
ανά: Glen, A, κ.ά.
Έκδοση: (2008)

Apigenin sensitizes prostate cancer cells to Apo2L/TRAIL by targeting adenine nucleotide translocase-2.
ανά: Masakatsu Oishi, κ.ά.
Έκδοση: (2013-01-01)

Trailing end-point phenotype antibiotic-sensitive strains of Candida albicans produce different amounts of aspartyl peptidases
ανά: L.A. Braga-Silva, κ.ά.
Έκδοση: (2009-08-01)

iTRAQ identification of candidate serum biomarkers associated with metastatic progression of human prostate cancer.
ανά: Rehman, I, κ.ά.
Έκδοση: (2012)

Diurnal variation of non-specular meteor trails
ανά: J. Hinrichs, κ.ά.
Έκδοση: (2009-05-01)

Global variation of meteor trail plasma turbulence
ανά: L. P. Dyrud, κ.ά.
Έκδοση: (2011-12-01)

Proteomic analysis of voided urine following prostatic massage reveals tumour specific alterations
ανά: Rehman, I, κ.ά.
Έκδοση: (2004)

Trail without Catheter after Transurethral Resection of Prostate: Clamp It or Not?
ανά: Vikash Talreja, κ.ά.
Έκδοση: (2016-01-01)

HTNV Sensitizes Host Toward TRAIL-Mediated Apoptosis—A Pivotal Anti-hantaviral Role of TRAIL
ανά: Qing-Zhou Chen, κ.ά.
Έκδοση: (2020-06-01)

Down-regulation of DcR2 sensitizes androgen-dependent prostate cancer LNCaP cells to TRAIL-induced apoptosis
ανά: Vindrieux David, κ.ά.
Έκδοση: (2011-12-01)